(Cyclopropylmethyl)[(trimethyl-1H-pyrazol-4-yl)methyl]amine

Catalog No. :
ACSOUY506
CAS No. :
1152608-31-5
Molecular Formula :
C11H19N3
Molecular Weight :
193.29

IUPAC Name:1-cyclopropyl-N-((1,3,5-trimethyl-1H-pyrazol-4-yl)methyl)methanamine

(Cyclopropylmethyl)[(trimethyl-1H-pyrazol-4-yl)methyl]amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$607.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Cyclopropylmethyl)[(trimethyl-1H-pyrazol-4-yl)methyl]amine
IUPAC Name1-cyclopropyl-N-((1,3,5-trimethyl-1H-pyrazol-4-yl)methyl)methanamine
MDL No.MFCD11157499
Molecular FormulaC11H19N3
Molecular Weight193.29
SMILESCN1N=C(C)C(CNCC2CC2)=C1C
InChI KeyKHXUKHOXLDPUGT-UHFFFAOYSA-N
Synonym1H-Pyrazole-4-methanamine, N-(cyclopropylmethyl)-1,3,5-trimethyl-;1-Cyclopropyl-N-((1,3,5-trimethyl-1h-pyrazol-4-yl)methyl)methanamine;N-(Cyclopropylmethyl)-1,3,5-trimethyl-1H-pyrazole-4-methanamine
CAS No.1152608-31-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSOUY506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBEDV352 route compound structure diagram
    ACBEDV3522644-93-1 In Stock
  2. Plus
  3. ACKYTW152 route compound structure diagram
    ACKYTW1522516-47-4 In Stock
  4. Then
  5. ACSOUY506 route product structure diagram
    ACSOUY5061152608-31-5
Inquiry

2. ACSOUY506 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSLXZ567 route compound structure diagram
    ACSLXZ567352018-93-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSOUY506 route product structure diagram
    ACSOUY5061152608-31-5
Inquiry

Comments (0)